India to test 100-yr-old vaccine on adults as war on Covid-19 hots up
Serum
Institute’s recombinant BCG vaccine would be the first vaccine candidate in
India to start human trials within the next two weeks. This is to test if the
vaccine, administered at birth to Indians to fight tuberculosis, can also boost
immunity in adults against the novel coronavirus.
If all
goes well, the vaccine, which has a proven safety track record, can be in the
market by the end of this year. Serum Institute can make 300-400 million doses
of this vaccine.
The
Bacillus Calmette-Gurein (BCG) vaccine named after French microbiologists
Albert Calmette and Camille Guérin, is given to infants in India upon birth.
Globally, the practice is to administer it to children below one year of age. Read More
Comments
Post a Comment